Catabolic factors and osteoarthritis-conditioned medium inhibit chondrogenesis of human mesenchymal stem cells

Tissue Engineering - Part A

Volumn 18, Issue 1-2, 2012, Pages 45-54

  Heldens, Genoveva T H ^a   Blaney Davidson, Esmeralda N ^a   Vitters, Elly L ^a   Schreurs, B Willem ^a   Piek, Ester ^b   Van Den Berg, Wim B ^a   Van Der Kraan, Peter M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; COLLAGEN; DATA STORAGE EQUIPMENT; GLYCOPROTEINS; JOINTS (ANATOMY); PELLETIZING; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ARTICULAR CARTILAGES; CATABOLIC FACTORS; CHONDROGENESIS; CHONDROGENIC DIFFERENTIATION; CHONDROGENIC MARKERS; CONDITIONED MEDIUM; DISEASED JOINTS; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); INHIBITORY EFFECT; INTERLEUKIN1; JOINT DAMAGES; PROGENITOR CELL; PROTEIN LEVEL; PROTEOGLYCANS; SYNOVIUM; TUMOR NECROSIS FACTORS; TYPE II;

CARTILAGE;

BONE MORPHOGENETIC PROTEIN 2; INTERLEUKIN 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CELL DIFFERENTIATION; CHONDROGENESIS; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; HUMAN; MALE; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS;

AGED; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CHONDROGENESIS; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOARTHRITIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855362192     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0083     Document Type: Article

References (33)

1. Lefebvre, V., and Smits, P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75, 200, 2005.
2. Gao, J., Yao, J.Q., and Caplan, A.I. Stem cells for tissue engineering of articular cartilage. Proc Inst Mech Eng H 221, 441, 2007.
3. Simon, T.M., and Jackson, D.W. Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc 14, 146, 2006.
4. Alford, J.W., and Cole, B.J. Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med 33, 295, 2005.
5. Temenoff, J.S., and Mikos, A.G. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21, 431, 2000.
6. Kirn-Safran, C.B., Gomes, R.R., Brown, A.J., and Carson, D.D. Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today 72, 69, 2004.
7. So, C.L., Kaluarachchi, K., Tam, P.P., and Cheah, K.S. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis Cartilage 9, S160, 2001.
8. Hunziker, E.B., and Rosenberg, L.C. Repair of partialthickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 78, 721, 1996.
9. Redman, S.N., Oldfield, S.F., and Archer, C.W. Current strategies for articular cartilage repair. Eur Cell Mater 9, 23, 2005.
10. Goldring, M.B. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2, 459, 2000.
11. Fernandes, J.C., Martel-Pelletier, J., and Pelletier, J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39, 237, 2002.
12. Kurth, T., Hedbom, E., Shintani, N., Sugimoto, M., Chen, F.H., Haspl, M., Martinovic, S., and Hunziker, E.B. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage 15, 1178, 2007.
13. Pelletier, J.P., Martel-Pelletier, J., Howell, D.S., Ghandur-Mnaymneh, L., Enis, J.E., and Woessner, J.F., Jr. Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 26, 63, 1983.
14. Saklatvala, J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322, 547, 1986.
15. Tyler, J.A. Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 227, 869, 1985.
16. Majumdar, M.K., Wang, E., and Morris, E.A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189, 275, 2001.
17. Brennan, F.M., Chantry, D., Jackson, A., Maini, R., and Feldmann, M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244, 1989.
18. Horiguchi, M., Akiyama, H., Ito, H., Shigeno, C., and Nakamura, T. Tumour necrosis factor-alpha up-regulates the expression of BMP-4 mRNA but inhibits chondrogenesis in mouse clonal chondrogenic EC cells, ATDC5. Cytokine 12, 526, 2000.
19. Hennerbichler, A., Moutos, F.T., Hennerbichler, D., Weinberg, J.B., and Guilak, F. Interleukin-1 and tumor necrosis factor alpha inhibit repair of the porcine meniscus in vitro. Osteoarthritis Cartilage 15, 1053, 2007.
20. Hashimoto, J., Yoshikawa, H., Takaoka, K., Shimizu, N., Masuhara, K., Tsuda, T., Miyamoto, S., and Ono, K. Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 10, 453, 1989.
21. Wehling, N., Palmer, G.D., Pilapil, C., Liu, F., Wells, J.W., Muller, P.E., Evans, C.H., and Porter, R.M. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaBdependent pathways. Arthritis Rheum 60, 801, 2009.
22. Sitcheran, R., Cogswell, P.C., and Baldwin, A.S., Jr. NFkappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17, 2368, 2003.
23. Wu, S., Fadoju, D., Rezvani, G., and De, L.F. Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem 283, 34037, 2008.
24. Feng, J.Q., Xing, L., Zhang, J.H., Zhao, M., Horn, D., Chan, J., Boyce, B.F., Harris, S.E., Mundy, G.R., and Chen, D. NFkappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278, 29130, 2003.
25. Rodrigo, J.J., Steadman, J.R., Syftestad, G., Benton, H., and Silliman, J. Effects of human knee synovial fluid on chondrogenesis in vitro. Am J Knee Surg 8, 124, 1995.
26. Mohamed-Ali, H. Influence of synovial cells on cartilage in vitro: induction of breakdown and inhibition of synthesis. Virchows Arch B Cell Pathol Incl Mol Pathol 62, 227, 1992.
27. Mohamed-Ali, H., Scholz, P., and Merker, H.J. Inhibition of the effects of rheumatoid synovial fluid cells on chondrogenesis and cartilage breakdown in vitro: possible therapeutical conclusions. A morphological-biochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 64, 45, 1993.
28. Morisset, S., Frisbie, D.D., Robbins, P.D., Nixon, A.J., and McIlwraith, C.W. IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects. Clin Orthop Relat Res 462, 221, 2007.
29. Hegewald, A.A., Ringe, J., Bartel, J., Kruger, I., Notter, M., Barnewitz, D., Kaps, C., and Sittinger, M. Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell 36, 431, 2004.
30. Chen, J., Wang, C., Lu, S., Wu, J., Guo, X., Duan, C., Dong, L., Song, Y., Zhang, J., Jing, D., Wu, L., Ding, J., and Li, D. In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res 319, 429, 2005.
31. Yang, K.G., Saris, D.B., Verbout, A.J., Creemers, L.B., and Dhert, W.J. The effect of synovial fluid from injured knee joints on in vitro chondrogenesis. Tissue Eng 12, 2957, 2006.
32. Saris, D.B., Dhert, W.J., and Verbout, A.J. Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg Br 85, 1067, 2003.
33. Lewis, P.B., McCarty, L.P., III, Kang, R.W., and Cole, B.J. Basic science and treatment options for articular cartilage injuries. J Orthop Sports Phys Ther 36, 717, 2006.